Clinical Trials

Home » Clinical Trials

ERT Showcased for Improving Patient Engagement in Clinical Trials

ERT, a global data and technology company that minimises uncertainty and risk in clinical trials, has announced that Karin Beckstrom, who heads up the company’s Innovation Lab, has been named a Top 20 Innovator by CenterWatch. CenterWatch’s list of Top 20 Innovators recognises the smart and talented industry representatives who are exploring and developing innovative products and [...]

BiondVax Plans Phase III Clinical Trial Following Receipt of Scientific Advice from EMA

BiondVax Pharmaceuticals Ltd has announced that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) reviewed BiondVax's Phase III trial plan, provided advice and allowed the company to proceed with the Phase III clinical trial plan for M-001, BiondVax's universal flu vaccine candidate. The CHMP advice will facilitate procedures in the countries [...]

Clinical Trial Transparency Reaches Highest Recorded Level

Timely reporting of results from pharmaceutical company sponsored clinical trials for newly approved medicines has reached the highest recorded level of 93%, according to a new study published in the peer-reviewed journal Current Medical Research and Opinion (CMRO). The ABPI-sponsored study – Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials [...]

Veeva Vault eTMF Helps Cancer Research UK Improve Clinical Trial Efficiency and Compliance

Veeva Systems has announced that Cancer Research UK selected Veeva Vault eTMF to modernise its clinical trial processes. The organisation currently sponsors and manages approximately 25 early phase oncology trials through its Centre for Drug Development. By improving regulatory compliance and increasing efficiency through active trial master file (TMF) management, Cancer Research UK aims to optimise development of [...]

Research Report on Patient Centricity Released by SCORR Marketing and KNect365

SCORR Marketing, a global health science marketing and communications firm, in partnership with KNect365, a leading business intelligence, academic publishing, knowledge and events business, has released the results of its Report: Patient-Centricity in Clinical Trials. The two companies conducted a survey to examine the perceptions, practices and future expectations of life science industry professionals regarding patient centricity in [...]

ReViral Initiates Phase IIa Study of RV521 to Treat Respiratory Syncytial Virus

Eddy Littler, CEO of ReViral ReViral, a UK-based biotech company focused on developing novel compounds targeting respiratory syncytial virus (RSV), announces that the first subjects have been dosed in a Phase IIa challenge study evaluating RV521 as an orally administered treatment for RSV infection. ReViral expects to report top-line data from this trial in [...]

Cmed to Demonstrate the Capture, Visualisation and Real-Time Analysis of Clinical Data using encapsia at Mobile in Clinical Trials and DPharm

David Connelly, CEO, Cmed Cmed has announced that it will present its encapsia clinical data suite at Mobile in Clinical Trials and DPharm: Disruptive Innovations to Advance Clinical Trials 2017. Attendees at both conferences will have the opportunity to learn about how encapsia streamlines the capture, management and reporting of clinical data, helping [...]

Onyx Helps Accelerate TopiVert’s Compounds to Clinic

British biotech business TopiVert has recently initiated clinical trials with two of its narrow spectrum kinase inhibitor (NSKI) drug candidates following support from Onyx Scientific. The contract research organisation (CRO) and small scale API specialist has assisted TopiVert with the rapid development of two key drug compounds. The biotech company is developing next-generation medicines for the treatment [...]

Interface Clinical Research Identifies Thousands of Patients for Feasibility Studies in a Number of Days

Interface Clinical Research has identified thousands of suitable patients for sponsors in feasibility studies for type 2 diabetes and chronic kidney disease (CKD). Interface was able to identify these patients from four of their GP practice sites across the UK in only a matter of days. Offering a new model for running primary care trials, [...]

Hovione Announces Phase I Clinical Trial to Treat a Subset of Anterior Ocular Inflammation

Hovione has announced the launch of its first clinical trial.  Hovione will soon initiate recruitment for its Phase I clinical trial of HY02, a proprietary minocycline sterile ointment to treat a subset of ocular surface inflammation, generally manifesting on the inner edge of the eyelids, leading to eye irritation and sometimes more severe symptoms such as blurring [...]